Products

Recordati Rare Diseases has a robust portfolio of therapies that target a wide range of medical conditions, and are designed to meet the needs of underserved patient populations.

Availability and regulatory status of our products may vary depending on the country. Please contact us to get more information.

Endocrinology

Oncology

Fotivda

  • This product is commercialised by EUSA Pharma (UK) Limited, a Recordati group company. More information can be found here.

Qarziba

  • This product is commercialised by EUSA Pharma (UK) Limited, a Recordati group company. More information can be found here.

Sylvant

  • This product is commercialised by EUSA Pharma (UK) Limited, a Recordati group company. More information can be found here.

Metabolic & other

 

 

Other Recordati Rare Diseases Products

CHEMET® (succimer) Capsules
Ibulief® (Ibuprofen lysine) Injection
NeoProfen® (Ibuprofen lysine) Injection
Foods for Special Medical Purposes :
DHA Basic
Feed PKU
KCalip